Tenofovir gel use associated with lower HSV-2 risk in women

da | postato in: Senza categoria | 0

The
risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by 46% (aIRR:0.54,
95%CI:0.30-0.97, p=0.038) among women who regularly used the vaginal gel
containing tenofovir, according to a secondary analysis of the Vaginal and Oral
Interventions to Control the Epidemic (VOICE) trial
presented at the HIV Research for
Prevention conference (R4P) in Cape Town,